Disease-free survival as the endpoint in multimodal rectal cancer trials: have we got this right?

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/42048

Title:	Disease-free survival as the endpoint in multimodal rectal cancer trials: have we got this right?
Authors:	Fokas, Emmanouil Roedel, Claus Smith, J. Joshua Garcia-Aguilar, Julio BUYSE, Marc Glynne-Jones, Robert
Issue Date:	2023
Publisher:	ELSEVIER INC
Source:	Lancet Gastroenterology & Hepatology, 8 (11) , p. 962 -964
Notes:	Fokas, E (corresponding author), Goethe Univ Frankfurt, Dept Radiotherapy Oncol, D-60590 Frankfurt, Germany.; Fokas, E (corresponding author), German Canc Res Ctr, Frankfurt, Germany.; Fokas, E (corresponding author), Frankfurt Canc Inst, Frankfurt, Germany. emmanouil.fokas@kgu.de
Document URI:	http://hdl.handle.net/1942/42048
e-ISSN:	2468-1253
DOI:	10.1016/S2468-1253(23)00231-5
ISI #:	001122935100001
Rights:	2023 Elsevier Ltd. All rights reserved.
Category:	A2
Type:	Journal Contribution
Appears in Collections:	Research publications

Check